Vyant Bio, Inc. EPS - Earnings per Share 2013-2023 | VYNT
Vyant Bio, Inc. eps - earnings per share from 2013 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Vyant Bio, Inc. Annual EPS |
| 2022 |
$-3.87 |
| 2021 |
$-9.03 |
| 2020 |
$-17.40 |
| 2019 |
$-17.40 |
| 2018 |
$-111.95 |
| 2017 |
$-151.65 |
| 2016 |
$-150.15 |
| 2015 |
$-294.29 |
| 2014 |
$-270.27 |
| 2013 |
$-546.55 |
| 2012 |
$-1,584.08 |
| 2011 |
$-2,343.84 |
| 2010 |
$-1,007.51 |
| Vyant Bio, Inc. Quarterly EPS |
| 2023-06-30 |
$-0.26 |
| 2023-03-31 |
$-0.71 |
| 2022-12-31 |
$-0.71 |
| 2022-09-30 |
$-0.59 |
| 2022-06-30 |
$-0.99 |
| 2022-03-31 |
$-1.58 |
| 2021-12-31 |
$3.99 |
| 2021-09-30 |
$-0.77 |
| 2021-06-30 |
$-0.70 |
| 2021-03-31 |
$-11.55 |
| 2020-12-31 |
$-4.70 |
| 2020-09-30 |
$-6.00 |
| 2020-06-30 |
$-2.70 |
| 2020-03-31 |
$-4.00 |
| 2019-12-31 |
$1.75 |
| 2019-09-30 |
$4.90 |
| 2019-06-30 |
$-9.90 |
| 2019-03-31 |
$-14.15 |
| 2018-12-31 |
$-21.71 |
| 2018-09-30 |
$-46.70 |
| 2018-06-30 |
$-19.52 |
| 2018-03-31 |
$-24.02 |
| 2017-12-31 |
$-28.53 |
| 2017-09-30 |
$-22.52 |
| 2017-06-30 |
$-24.02 |
| 2017-03-31 |
$-76.58 |
| 2016-12-31 |
$-15.02 |
| 2016-09-30 |
$-34.54 |
| 2016-06-30 |
$-42.04 |
| 2016-03-31 |
$-58.56 |
| 2015-12-31 |
$-67.57 |
| 2015-09-30 |
$-84.08 |
| 2015-06-30 |
$-76.58 |
| 2015-03-31 |
$-66.07 |
| 2014-12-31 |
$-82.58 |
| 2014-09-30 |
$-76.58 |
| 2014-06-30 |
$-70.57 |
| 2014-03-31 |
$-40.54 |
| 2013-12-31 |
$216.22 |
| 2013-09-30 |
$-91.59 |
| 2013-06-30 |
$-343.84 |
| 2013-03-31 |
$-327.33 |
| 2012-12-31 |
$-623.12 |
| 2012-09-30 |
$-334.84 |
| 2012-06-30 |
$-348.35 |
| 2012-03-31 |
$-277.78 |
